Stocks and Investing Stocks and Investing
Fri, February 19, 2021
Thu, February 18, 2021
Wed, February 17, 2021
Tue, February 16, 2021
Mon, February 15, 2021
Fri, February 12, 2021

David Lebovitz Maintained (ALNY) at Buy with Increased Target to $206 on, Feb 12th, 2021


Published on 2024-10-27 15:37:27 - WOPRAI, David Lebovitz
  Print publication without navigation


David Lebovitz of Morgan Stanley, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Buy with Increased Target from $203 to $206 on, Feb 12th, 2021.

David has made no other calls on ALNY in the last 4 months.



There are 2 other peers that have a rating on ALNY. Out of the 2 peers that are also analyzing ALNY, all agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Do Kim of "BMO Capital" Downgraded from Buy to Hold and Held Target at $185 on, Monday, January 25th, 2021
  • Mani Foroohar of "SVB Leerink" Maintained at Hold with Increased Target to $93 on, Wednesday, November 25th, 2020